NASDAQ:FBIO - Fortress Biotech, Inc.
$2.20
 $0.03
+1.38%
2:45PM EDT
2019-02-15
Fortress Biotech, Inc., formerly Coronado Biosciences, Inc., is a biopharmaceutical company. The Company is involved in the development of immunotherapy agents for the treatment of autoimmune diseases and cancer. Its sole product candidate is CNDO-109. The Company is also focused on acquiring, developing and commercializing pharmaceutical and biotechnology products. The Company's product, CNDO-109, is a lysate (disrupted Closteroviridae (CTV)-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor Natural Killer (NK) cells. CTV-1 is a leukemic cell line re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company holds the license to develop and commercialize CNDO-109 to activate NK cells for the treatment of cancer-related and other conditions, and a non-exclusive license to certain clinical data solely for use in the Investigational new drug (IND) for CNDO-109. The Company is conducting the Phase I clinical studies of CNDO-109. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  FBIO     avg for
industry  
  avg for
sector  
42 stocks weight:  45. 99   0. 00   0. 00  
42 stocks rank:  2. 87 K 1. 86 K 1. 09 K
# analyst opinions:  2. 00   14. 92   14. 43  
mean recommendation:  2. 00   1. 91   1. 93  

quick ratio:  1. 99   5. 37   1. 81  
current ratio:  2. 25   5. 69   2. 19  

target price low:  3. 50   88. 97   117. 82  
target price avg:  3. 50   115. 19   141. 96  
target price high:  3. 50   143. 40   163. 16  
1-yr high:  5. 35   124. 30   142. 77  
last close:  2. 17   101. 85   127. 84  
50-day avg:  1. 31   98. 27   122. 46  
200-day avg:  1. 99   99. 72   122. 70  
1-yr low:  0. 57   78. 19   100. 16  
volume:  481. 43 K 2. 38 M 4. 64 M
50-day avg volume:  670. 80 K 3. 31 M 4. 94 M
200-day avg volume:  335. 97 K 3. 23 M 4. 28 M

1-day return:  -0. 46 % 0. 22 % 0. 48 %
this week return:  1. 88 % 1. 77 % 2. 01 %
12-wk return:  63. 16 % 6. 56 % 3. 33 %
52-wk return:  -39. 24 % -2. 23 % 14. 35 %

enterprise value (EV):  126. 41 M 55. 17 B 104. 51 B
market cap:  122. 99 M 49. 01 B 96. 46 B
EBITDA:  -107. 97 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -1. 17   -91. 79   2. 29  
enterprise/revenue (EV/R):  0. 55   29. 84   23. 39  
total revenue:  228. 27 M 11. 28 B 40. 22 B
total debt:  84. 26 M 13. 73 B 16. 57 B
debt/equity:  99. 55   258. 01   110. 73  
net income (common):  -69. 68 M 2. 37 B 3. 58 B

shares outstanding:  56. 68 M 607. 99 M 1. 22 B
shares:  33. 54 M 605. 53 M 1. 15 B
shares short:  894. 12 K 11. 62 M 12. 55 M
shares short prior month:  906. 62 K 11. 95 M 13. 44 M
short ratio:  1. 49   4. 82   3. 10  
short % of float:  2. 67 % 6. 19 % 2. 82 %
total cash/share:  2. 17   12. 02   11. 46  
total cash:  123. 17 M 7. 41 B 7. 37 B
free cash flow:  -77. 97 M 95. 99 M 2. 04 B
operating cash flow:  -102. 82 M 164. 74 M 3. 04 B

book value:  0. 67   14. 43   28. 26  
price/book:  3. 23   -1. 57   -2. 97  
gross profits:  24. 67 M 8. 28 B 18. 09 B
operating margins:  -49. 40 % -458. 01 % -642. 83 %
EBITDA margins:  -47. 30 % 13. 81 % 22. 47 %
profit margins:  -30. 53 % 6. 57 % 9. 92 %
gross margins:  17. 17 % 49. 33 % 54. 53 %

1-yr max volatility:  39. 86 % --- ---
1-yr mean volatility:  0. 05 % 0. 01 % 0. 06 %

1-yr EPS:  -1. 59   3. 03   4. 09  
forward EPS:  -2. 45   4. 33   6. 99  
P/E:  -1. 37   6. 11   26. 91  
forward P/E:  -0. 87   8. 38   10. 48  
PE/G:  -0. 04   0. 37   5. 61  
growth:  35. 80 % 683. 72 % 104. 79 %
earnings high:  -0. 00   1. 27   1. 66  
earnings avg:  -0. 00   1. 01   1. 53  
earnings low:  -0. 00   0. 76   1. 40  
revenue high:  67. 65 M 2. 86 B 11. 19 B
revenue avg:  67. 65 M 2. 78 B 10. 84 B
revenue low:  67. 65 M 2. 67 B 10. 64 B
return on assets:  -29. 99 % -3. 27 % 3. 81 %
return on equity:  -124. 86 % 107. 48 % 27. 82 %
revenue growth:  35. 80 % 648. 36 % 97. 70 %
revenue/share:  5. 20   14. 68   59. 83  

beta (1yr vs S&P500):  1. 30   1. 21   0. 93  
sharpe (1yr):  0. 10   0. 06   0. 98  

held % insiders:  31. 10 % 6. 46 % 3. 21 %
held % institutions:  14. 94 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : FBIO
.        + 0 =             0 :: INITIAL WEIGHT
. + 1327.564 =      1327.564 :: inverse volume-to-price addition
.  + 209.242 =      1536.806 :: spline projection addition
.  - 237.753 =      1299.053 :: poor performance penalty
.    x 0.767 =       996.828 :: one-year gains+dividend factor
.    x 9.639 =      9608.668 :: 13 weeks' performance factor
.    x 1.492 =      14340.83 :: industry recommendation factor
.    x 2.098 =     30089.388 :: symbol recommendation factor
.    x 1.019 =     30648.094 :: EV/R factor
.    x 0.997 =     30556.171 :: return on assets factor
.    x 0.988 =     30174.662 :: return on equity factor
.    x 2.228 =     67216.021 :: revenue growth factor
.    x 2.396 =     161041.89 :: current ratio factor
.    x 1.416 =    228005.437 :: quick ratio factor
.    x 1.293 =    294748.594 :: short ratio factor
.    x 2.032 =    599015.112 :: price-to-book factor
.    x 1.177 =    705170.601 :: debt-to-equity factor
.    x 1.077 =     759373.55 :: 5-day avg > 200-day avg
.    x 1.629 =   1237103.682 :: 5-day avg > 50-day avg
.    x 2.169 =   2682840.861 :: P/E weight
.    x 2.209 =    5926285.77 :: PE/G factor
.    x 1.456 =   8627142.858 :: beta factor
.    x 0.105 =    905452.594 :: sharpe factor
.     x 1.85 =   1675457.835 :: target low factor
.    x 1.261 =   2112917.568 :: target mean factor
.    x 1.078 =   2278421.529 :: target high factor
.    x 1.066 =    2427915.16 :: industry 12-weeks return
.      x 1.0 =   2427347.285 :: overall "drift" factor
.    x 0.601 =    1459688.57 :: largest single-day jump factor
.    x 0.067 =      97247.74 :: low price factor
.      x 1.0 =     97254.267 :: factor hist industry gain for week 06
.   cubeRoot =        45.987 :: reduced for readability
.                     45.987 :: FINAL WEIGHT for NASDAQ:FBIO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org